Skip to main content
TipRanks
Go Ultimate75% OFF

Ionis Pharmaceuticals (IONS) Revenue by Segment

1,674 Followers

Revenue by Segment

Ionis Pharmaceuticals reported revenue by segment of $267.90M in Q2 2026, up 8.9% from Q1 2026 and down 40.7% year over year. The highest value was $452.05M in Q2 2025.

Breaks down revenue by business segments, revealing the company's strategic focus areas and how each segment contributes to overall financial performance.

$0.00$100.00M$200.00M$300.00M$400.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

Ionis’ top line is transitioning from lumpy, milestone-driven R&D/collaboration receipts to meaningful, scaling product sales: 2025 shows a clear commercial ramp as launches and growing royalties supplement still‑large but episodic R&D income. That mix creates pronounced quarter-to-quarter volatility and makes near‑term guidance highly sensitive to FDA timing and partner milestones; the real test for investors is whether sustained commercial momentum (and pricing/payer wins) can replace irregular collaboration windfalls to stabilize revenue going forward.

IONS Revenue by Segment

PeriodCommercialResearch and DevelopmentTotal
Q2 2026Jun 30, 2026$118.60M$149.30M$267.90M
Q1 2026Mar 31, 2026$108.00M$138.00M$246.00M
Q4 2025Dec 31, 2025$141.00M$62.00M$203.00M
Q3 2025Sep 30, 2025$116.00M$41.00M$157.00M
Q2 2025Jun 30, 2025$102.76M$349.29M$452.05M
Q1 2025Mar 31, 2025$76.17M$55.44M$131.61M
Q4 2024Dec 31, 2024$86.00M$141.00M$227.00M
Q3 2024Sep 30, 2024$75.73M$58.08M$133.81M
Q2 2024Jun 30, 2024$72.04M$153.21M$225.25M
Q1 2024Mar 31, 2024$59.59M$59.90M$119.50M
Q4 2023Dec 31, 2023$79.00M$246.00M$325.00M
Q3 2023Sep 30, 2023$84.08M$60.13M$144.21M
Q2 2023Jun 30, 2023$77.90M$110.51M$188.41M
Q1 2023Mar 31, 2023$67.77M$62.76M$130.52M
Q4 2022Dec 31, 2022$80.00M$72.00M$152.00M
Q3 2022Sep 30, 2022$72.41M$87.36M$159.77M
Q2 2022Jun 30, 2022$78.18M$55.61M$133.79M
Q1 2022Mar 31, 2022$72.28M$69.63M$141.92M
Q4 2021Dec 31, 2021$87.00M$353.00M$440.00M
Q3 2021Sep 30, 2021$84.82M$48.27M$133.09M
Q2 2021Jun 30, 2021$85.86M$39.89M$125.75M
Q1 2021Mar 31, 2021$84.45M$27.16M$111.61M
Q4 2020Dec 31, 2020$96.00M$194.00M$290.00M
Q3 2020Sep 30, 2020$95.00M$65.00M$160.00M
Q2 2020Jun 30, 2020$90.00M$56.00M$146.00M
Q1 2020Mar 31, 2020$84.00M$49.00M$133.00M

Related KPIs